Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice

• Published in: PLoS genetics Vol. 15; no. 4; p. e1008069
• Main Authors: Volpi, Vera G., Ferri, Cinzia, Fregno, Ilaria, Del Carro, Ubaldo, Bianchi, Francesca, Scapin, Cristina, Pettinato, Emanuela, Solda, Tatiana, Feltri, M. Laura, Molinari, Maurizio, Wrabetz, Lawrence, D’Antonio, Maurizio
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 17.04.2019
• Subjects: Age; Aging; Animals; Biochemistry; Biology; Biomarkers; Cell Line; Charcot-Marie-Tooth disease; Clonal deletion; Demyelinating Diseases - genetics; Demyelinating Diseases - metabolism; Demyelinating Diseases - pathology; Demyelination; Displays (Marketing); Endoplasmic reticulum; Endoplasmic Reticulum-Associated Degradation; Fluorescent Antibody Technique; Gene deletion; Gene Expression Profiling; Genetic disorders; Glucosamine; Glycoproteins; Homeostasis; Humans; Hypotheses; Kinases; Medicine; Mice; Mutation; Myelin P0 protein; Myelin proteins; Myelin Sheath - metabolism; Myelination; N-Acetyl-D-glucosamine; N-Acetylglucosamine; Nervous system; Neurology; Neurons; Neuropathy; Neurosciences; Peripheral nerves; Peripheral Nerves - metabolism; Peripheral Nerves - ultrastructure; Peripheral neuropathy; Physiological aspects; Proteasomes; Protein folding; Proteins; Quality control; Schwann cells; Schwann Cells - metabolism; Sciatic Nerve - metabolism; Serine; Stress response; Tetracyclines; New York; Italy; United States > US; Switzerland
• ISSN: 1553-7404; 1553-7390; 1553-7404
• DOI: 10.1371/journal.pgen.1008069

In the peripheral nervous system (PNS) myelinating Schwann cells synthesize large amounts of myelin protein zero (P0) glycoprotein, an abundant component of peripheral nerve myelin. In humans, mutations in P0 cause the demyelinating Charcot-Marie-Tooth 1B (CMT1B) neuropathy, one of the most diffused genetic disorders of the PNS. We previously showed that several mutations, such as the deletion of serine 63 (P0-S63del), result in misfolding and accumulation of P0 in the endoplasmic reticulum (ER), with activation of the unfolded protein response (UPR). In addition, we observed that S63del mouse nerves display the upregulation of many ER-associated degradation (ERAD) genes, suggesting a possible involvement of this pathway in the clearance of the mutant P0. In ERAD in fact, misfolded proteins are dislocated from the ER and targeted for proteasomal degradation. Taking advantage of inducible cells that express the ER retained P0, here we show that the P0-S63del glycoprotein is degraded via ERAD. Moreover, we provide strong evidence that the Schwann cell-specific ablation of the ERAD factor Derlin-2 in S63del nerves exacerbates both the myelin defects and the UPR in vivo, unveiling a protective role for ERAD in CMT1B neuropathy. We also found that lack of Derlin-2 affects adult myelin maintenance in normal nerves, without compromising their development, pinpointing ERAD as a previously unrecognized player in preserving Schwann cells homeostasis in adulthood. Finally, we provide evidence that treatment of S63del peripheral nerve cultures with N-Acetyl-D-Glucosamine (GlcNAc), known to enhance protein quality control pathways in C.elegans, ameliorates S63del nerve myelination ex vivo. Overall, our study suggests that potentiating adaptive ER quality control pathways might represent an appealing strategy to treat both conformational and age-related PNS disorders.